
Join to View Full Profile
201 North Broadway StreetViragh BLDG 5th FLBaltimore, MD 21287
Phone+1 410-955-8964
Fax+1 410-367-2194
Dr. Shenderov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2016 - 2018
- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2013 - 2016
- Johns Hopkins University School of MedicineClass of 2013, MD
- University of OxfordD.Phil, Tumour Immunology, 2005 - 2009
Certifications & Licensure
- DC State Medical License 2023 - 2027
- PA State Medical License 2024 - 2026
- VA State Medical License 2023 - 2026
- MD State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer Start of enrollment: 2024 Feb 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Hypothermic machine perfusion prevents hyperacute graft loss in pig-to-primate kidney xenotransplantation after 5-hours of cold Ischemia.Yu Hisadome, Daniel L Eisenson, WeiLi Chen, Alexander C Schulick, Adam Luo
Communications Medicine. 2025-04-15 - 1 citationsNectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study.Ezra G Baraban, Evangelia Vlachou, Sunil Patel, Max Kates, Burles Johnson
The Prostate. 2025-04-01 - 1 citationsRoutine cold storage leads to hyperacute graft loss in pig-to-primate kidney xenotransplantation; hypothermic machine perfusion may be preferred preservation modality ...Kazuhiko Yamada, Yu Hisadome, Daniel Eisenson, WeiLi Chen, Alex Schulick
Research Square. 2024-12-18
Press Mentions
- Immunotherapy Could Be Effective for Treating Prostate Cancer: StudyApril 9th, 2023
- Health News | Immunotherapy Could Be Effective for Treatment of Prostate Cancer: StudyApril 9th, 2023
- Study Shows How Novel Immunotherapy Helps Fight High-Risk Prostate Cancer, ET HealthWorldApril 8th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: